Cyclacel Pharmaceuticals Aktie - CYCC

Cyclacel Pharmaceuticals Inc (CYCC) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

6,365

( - )

Gebot

6,21

Fragen

6,67

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

35,131M

Handelsende

6,365

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

US$ 86.855

Ausgegebene Aktien

5.519.456

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-0,36

Gewinn pro Aktie (EPS)

-4,11

Erlöse (LTM)

1,53M

Nettogewinn (LTM)

-3,11M

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharma... Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. Mehr anzeigen

Sektor

Healthcare

Branche

Biotechnology & Life Sciences

Website

bgmsglobal.com

Hauptsitz

Kuala Lumpur, Malaysia

Gegründet

1996

Cyclacel Pharmaceuticals Inc is listed in the Healthcare sector of the NASDAQ with ticker CYCC. The last closing price for Cyclacel Pharmaceuticals was US$6,37. Over the last year, Cyclacel Pharmaceuticals shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Cyclacel Pharmaceuticals currently has 5.519.456 shares in issue. The market capitalisation of Cyclacel Pharmaceuticals is US$35,13 million. Cyclacel Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.36.

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the...

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC...

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA...

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC...

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

- Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CYCC - Frequently Asked Questions (FAQ)

What is the current Cyclacel Pharmaceuticals Inc share price?

The current share price of Cyclacel Pharmaceuticals Inc is US$ 6,365

How many Cyclacel Pharmaceuticals Inc shares are in issue?

Cyclacel Pharmaceuticals Inc has 5.519.456 shares in issue

What is the market cap of Cyclacel Pharmaceuticals Inc?

The market capitalisation of Cyclacel Pharmaceuticals Inc is USD 35,13M

What is the 1 year trading range for Cyclacel Pharmaceuticals Inc share price?

Cyclacel Pharmaceuticals Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Cyclacel Pharmaceuticals Inc?

The price to earnings ratio of Cyclacel Pharmaceuticals Inc is -0,36

What is the cash to sales ratio of Cyclacel Pharmaceuticals Inc?

The cash to sales ratio of Cyclacel Pharmaceuticals Inc is 3,8

What is the registered address of Cyclacel Pharmaceuticals Inc?

The registered address for Cyclacel Pharmaceuticals Inc is Level 10, Kuala Lumpur, Wilayah Persekutuan, 592000

What is the Cyclacel Pharmaceuticals Inc website address?

The website address for Cyclacel Pharmaceuticals Inc is bgmsglobal.com

Which industry sector does Cyclacel Pharmaceuticals Inc operate in?

Cyclacel Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc (CYCC) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Cyclacel Pharmaceuticals Inc

CYCC Neueste Nachrichten

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

Cyclacel Pharmaceuticals Announces Stock Split

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

Cyclacel stock dips after trimming 270% surge amid volatility concerns

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Cyclacel Pharmaceuticals Announces Stock Split

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCC - Frequently Asked Questions (FAQ)

CYCC Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS